How Datavault AI Inc. is turning U.S. critical minerals into digital assets through American Strategic Minerals Inc. deal (NASDAQ: DVLT)
Spectral Medical (TSX: EDT) posts C$2.44m revenue as PMA submission slips to May 2026 and derivative liabilities widen the reported loss
Oxford Biomedica (LSE: OXB) delivers first EBITDA profit as revenue surges 33% and BMS CAR-T deal signals commercial maturity
Read More 1 minute read Pharma Industry News Galera Therapeutics enrolls patients for pancreatic cancer trial of GC4419 Galera Therapeutics said that it has wrapped up enrollment of patients for its phase 1b/2a safety and anti-cancer… bypharmanewsdailyJuly 14, 2020